| 國立成功大學 |
2021-08 |
Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics
|
Hung;Yuan-Pin;Lee;Ching-Chi;Lee;Jen-Chieh;Tsai;Pei-Jane;Ko;Wen-Chien |
| 國家衛生研究院 |
2025-12-26 |
Gut microbes with the gbu genes determine TMAO production from L-carnitine intake and serve as a biomarker for precision nutrition
|
Wu, WK;Lo, YL;Chiu, JY;Hsu, CL;Lo, IH;Panyod, S;Liao, YC;Chiu, THT;Yang, YT;Kuo, HC;Zou, HB;Chen, YH;Chuang, HL;Yen, JJY;Wang, JT;Chiu, HM;Hsu, CC;Kuo, CH;Sheen, LY;Kao, HL;Wu, MS |
| 臺大學術典藏 |
2021-06-15T03:11:47Z |
Gut Microbial Transcytosis Induced by Tumour Necrosis Factor-like 1A-dependent Activation of a Myosin Light Chain Kinase Splice Variant Contributes to Inflammatory Bowel Disease
|
Pai Y.-C.; Weng L.-T.; SHU-CHEN WEI; Wu L.-L.; Shih D.Q.; Targan S.R.; Turner J.R.; Yu L.C.-H. |
| 臺大學術典藏 |
2022-02-15T06:22:45Z |
Gut Microbial Transcytosis Induced by Tumour Necrosis Factor-like 1A-dependent Activation of a Myosin Light Chain Kinase Splice Variant Contributes to Inflammatory Bowel Disease
|
Pai Y.-C.; Weng L.-T.; Wei S.-C.; Wu L.-L.; Shih D.Q.; Targan S.R.; Turner J.R.; LINDA CHIA-HUI YU |
| 國立交通大學 |
2019-04-02T06:00:57Z |
Gut microbiome changes in overweight male adults following bowel preparation
|
Chen, Hui-Mei; Chen, Chung-Chu; Chen, Chien-Chi; Wang, Shen-Chih; Wang, Chun-Lin; Huang, Chien-Hsun; Liou, Jong-Shian; Liu, Ta-Wei; Peng, Hwei-Ling; Lin, Feng-Mao; Liu, Chia-Yuan; Weng, Shun-Long; Cheng, Chieh-Jen; Hung, Yi-Fang; Liao, Chii-Cherng; Huang, Hsien-Da |
| 臺大學術典藏 |
2022-02-18T08:25:51Z |
Gut microbiome in Parkinson's disease: New insights from meta-analysis
|
Toh T.S.; Chong C.W.; Lim S.-Y.; Bowman J.; Cirstea M.; Lin C.-H.; CHIEH-CHANG CHEN; Appel-Cresswell S.; Finlay B.B.; Tan A.H. |
| 臺大學術典藏 |
2022-09-15T02:44:12Z |
Gut microbiome in Parkinson's disease: New insights from meta-analysis
|
Toh T.S.; Chong C.W.; Lim S.-Y.; Bowman J.; Cirstea M.; CHIN-HSIEN LIN; Chen C.-C.; Appel-Cresswell S.; Finlay B.B.; Tan A.H. |
| 臺大學術典藏 |
2019 |
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
|
Chiu H.-Y.; TSEN-FANG TSAI; Hsu C.-Y.; Yeh N.-L.; Yeh N.-L.;Hsu C.-Y.;Tsen-Fang Tsai;Chiu H.-Y. |
| 臺大學術典藏 |
2022-01-11T06:49:28Z |
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
|
Yeh N.-L.; Hsu C.-Y.; Tsai T.-F.; HSIEN-YI CHIU |
| 臺大學術典藏 |
2020-12-28T08:14:07Z |
Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease
|
Yang Y.-J.; YEN-HSUAN NI |
